Offerings - Offering: 1 |
Oct. 09, 2026
USD ($)
shares
|
|---|---|
| Offering: | |
| Fee Previously Paid | false |
| Other Rule | true |
| Security Type | Equity |
| Security Class Title | Common Stock, $0.0001 par value per share |
| Amount Registered | shares | 2,908,692 |
| Proposed Maximum Offering Price per Unit | 72.66 |
| Maximum Aggregate Offering Price | $ 211,345,560.72 |
| Fee Rate | 0.0087% |
| Amount of Registration Fee | $ 18,387.06 |
| Offering Note | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall also cover any additional shares of common stock, $0.0001 par value per share (the "Common Stock"), of Tarsus Pharmaceuticals, Inc. (the "Registrant"), which may become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that results in an increase in the number of the outstanding shares of the Registrant's Common Stock, as applicable. The shares of the Registrant's Common Stock being registered hereunder are being registered for sale by the selling stockholders named in this registration statement and represent 2,908,692 shares of the Registrant's Common Stock. Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is $72.66, which is the average of the high and low prices of shares of the Registrant's Common Stock on the Nasdaq Global Select Market on October 8, 2026 (such date being within five business days of the date that this registration statement was filed with the U.S. Securities and Exchange Commission). |